A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight
Conditions: Obesity; Non-Alcoholic SteatoHepatitis (NASH) Interventions: Drug: Survodutide; Drug: Placebo Sponsors: Boehringer Ingelheim Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alcoholism | Eating Disorders & Weight Management | Liver | Liver Disease | Obesity | Research | Study | Urology & Nephrology